Abstract
Epidemiologically, the Acquired Immune Deficiency Syndrome, AIDS, is transmitted and distributed in the USA and Europe almost entirely in well-defined subsets of populations engaging in, or subjected to, the effects of behaviours which carry high risks of genital and systemic infections. The persons predominantly affected are those engaging in promiscuous homosexual and bisexual activity, regular use of addictive drugs, and their sexual and recreational partners. In such persons and in subsets of populations with corresponding life-styles, the risk of AIDS increases by orders of magnitude. Because of continuity of risk behaviour and of associated indicator infections, the incidence of AIDS over 3–5 year periods is predictable to within 10% of actual totals of registered cases in the USA and UK. Secondary transmission of AIDS beyond these groups is minimal or, in many locations, absent. There is no indication of appreciable spread by heterosexual transmission to the general population.
The Human Immunodeficiency Virus, HIV, is transmissible to some extent in general populations, and more so among promiscuous persons. It may cause viraemia, lymphadenopathy and latent infection (HIV disease) in anyone. In persons engaging in risk behaviours which themselves alter or suppress immune responses, it can interact with MHC, antibodies to other organisms and to semen, and other allogenic antigens to initiate a programmed death of CD4 lymphocytes and other defensive cells, as in graft-host rejections. This occurs also in haemophiliacs receiving transfusions of blood products, and is more pronounced in persons with reactive HLA haplotypes. The susceptibility of particular subsets of populations to AIDS is thereby largely explained. But these changes occur in the absence of HIV, and so do Kaposi’s sarcoma, lymphadenopathies and opportunistic infections which are regarded as main indicators of AIDS. The hypothesis that HIV-1 can do all this by itself and thereby cause AIDS is falsifiable on biological as well as epidemiological grounds.
An alternative hypothesis is proposed, linking the incidence of AIDS to the evolution of contemporary risk behaviour in particular communities and locations in the USA, UK and probably in most of Europe. It does not pretend to explain the reported incidence of AIDS in Africa and other developing regions where data are insufficient to provide validation of the pattern of disease and contributory variables.
The immediate, practical implication of this alternative hypothesis is that existing programmes for the control of AIDS are wrongly orientated, extremely wasteful of effort and expenditure, and in some respects harmful.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Aboulker, J-P. & A-M Swart, 1993. Preliminary analysis of the Concorde Trial. Lancet 341: 889–90.
Acquired Immune Deficiency Syndrome (AIDS) in England & Wales to the end of 1993. 1990. Report of a Working Group convened by the Director of the Public Health Laboratory Service, London, HMSO.
Adams, J.A.D., 1988. AIDS: the HIV myth. London: Macmillans.
Adams, L.E., R. Donovan-Brand & A. Friedman-Kien, 1988. Sperm and seminal plasma antibodies in AIDS. Clin. Immunol. Immunopathol. 46: 442.
Ades, A.E., S. Parker & D. Cubitt, 1992. Two methods for assessing risk-factor composition of the HIV-1 epidemic in heterosexual women: Southeast England, 1981–1991. AIDS 6(9): 1031–6.
Advisory Committee on Dangerous Pathogens, January 1990. HIV - the causative agent of AIDS and related conditions, 2nd revision; London, HMSO.
Agency for Health and Welfare Services, California. Nov. 8, 1995. AIDS in San Francisco; California Morbidity Reports.
Amer. Assoc. Adv. Sci. Policy Forum (AIDS). 1988. Science 241: 514–7.
Anderson, R.M. & R.M. May, 1987. Transmission dynamics of the Human Immune Deficiency Virus (HIV). Nature 326: 137–42.
Ascher, M.S. & H.W. Sheppard, 1988. AIDS as immune system activation: a model for pathogenesis. Clin. Exp. Immunol. 73: 165–7.
Ashida, E.R. & F.L. Schofield, 1987. Lymphocyte major histocompatability complex-encoded class II structures may act as sperm receptors. Proc. Nat. Acad. Sci. USA 84: 3395.
Baltimore, D. & M.B. Feinberg, 1989. Editorial: HIV revealed. New Eng. J. Med. 321: 1673.
Barre-Sinoussi, E, J.C. Chermann & F Rey, 1983. Isolation of a T-lymphotropic virus from a patient at risk for AIDS. Science 220: 868–70.
Beral, V., D. Bull & S. Darby, 1990. Kaposi’s sarcoma and sexual practice associated with faecal contact in homosexual or bisexual men with AIDS. Lancet 339: 632–6.
Berkley, S.F., R. Widi-Wirski & S.I. Odware, 1989. Risk Factors associated with HIV infection in Uganda. J. Inf. Dis. 160: 22–30.
Beverly, P.C.L., 1991. Is T-cell memory maintained by cross-reactive stimulation? Immunol. Today 11: 203–205.
Blattner, W., R.C. Gallo & H. Tenin, 1988. HIV causes AIDS. Science 241:5141–3.
Bregman, J. & A. Langmuir, 1990. Farr’s Law applied to AIDS projection. JAMA 236: 1522–5.
Capel, W., B. Goldsmith & G.T. Stewart, 1972. The ageing narcotic addict. J. Gerontol. 27: 102–10.
Carlin, R., B.M. Peterlin & D. Derse, 1992. Inhibition of HIV-1 Tat activity by co-expression of heterologous transactivators. J. Virol. 66(4): 2000–7.
Carr, E., E. Edmond & R.J. Prescott, 1984. Abnormalities of circulating lymphocyte subsets in haemophiliacs in an AIDS-free population. Lancet 1: 1431–4.
Cheesbro, B., K. Wehrly, Nishio & S. Perryman, 1992. Macrophage-tropic HIV isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell tropic isolates. J. Virol. 66(11): 6547–54.
Concorde: 1993. MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection. Lancet 343: 871–81.
Courouce, A., A. Muller & B. Richard, 1986. False-positive western blot reactions to HIV-1 in blood donors. Lancet 2: 921–2.
Cox, D.R., R.M. Anderson & H.C. Hiller (ed), 1989. Epidemiological and statistical aspects of the AIDS epidemic. Phil. Trans. S. Soc. Lond. (B) 325: 37–187.
Craven, B.M., G.T. Stewart & M. Taghavi, 1994. Amateurs confronting specialists: Expenditure on AIDS in England. J. Pub. Policy 13: 305–325.
Creglev, L.L. & H. Mark, 1986. Medical complications of cocaine abuse. New Eng. J. Med. 315: 1495.
D’Arminio, M.A., L. Vago & A. Lazzarin, 1992. AIDS-defining diseases of 250 HIV-infected patients: a comparative study of clinical and autopsy diagnosis. AIDS 6: 1159–64.
Dalgleish, A. & R.A. Weiss, 1984. Prevalence of antibodies to human T-cell lymphotropic virus type 3 in AIDS and AIDS-risk patients in Britain. Lancet 2: 477–80.
Dalgleish, A.G., P.C.L. Beverley & P.R. Clapham, 1985. The CD4 (T4) antigen is an essential component of the receptors for the AIDS retrovirus. Nature 312: 763–7.
Dalgleish, A.G., S. Wilson & S. Gompels, 1992. T-cell receptor variable gene-products and early HIV infection. Lancet 339: 824–6.
Daniel, V., K. Schimpf & G. Opelz, 1989. Lymphocyte antibodies and allo-antibodies in HIV-positive haemophilia patients. Clin. Exp. Immunol. 75: 178–183.
Darby, S.C., C.R. Rizza & R. Doll, 1989. Incidence of AIDS and excess mortality associated with HIV in haemophiliacs in the UK. Report on behalf of the Directors of Haemophiliac Centres in the UK. Brit. Med. J. 298: 1064–8.
Davey, R.T., L.R. Dayton & J.A. Metcalf, 1992. Indeterminate WB patterns in a cohort at high risk for HIV exposure. J. Clin. Immunol. 12(3): 185–92
de Biasi, R., A. Rocino & E. Miraglia, 1991. The impact of very high purity Factor VIII concentrate on the immune system of HIV-infected haemophiliacs: a randomized, prospective two-year comparison with an intermediate purity concentrate. Blood 78: 1919–22.
De Cock, K.M., B. Soro, I.M. Coulibaly & S.B. Lucas, 1992. Tuberculosis and HIV infection in sub-Saharan Africa. JAMA 268: 1581–7.
Dept of Health and Welsh Office, 1988. Short-term prediction of HIV infection and AIDS; report of a working group (Chairman: Sir D. Cox), London, HMSO.
Detels, R., P. English & B.R. Visscher, 1989. Seroconversion, sexual activity and condom use among 2,915 seronegative men followed for up to two years. J. AIDS 2: 77–83.
Drew, W.L., J. Mills & J. Levy, 1985. Cytomegalovirus infection and abnormal T-lymphocyte subset ratios in homosexual men. Ann. Int. Med. 103: 61–3.
Duesberg, P.H. & J.R. Schwartz, 1992. Latent viruses and mutated oncongenes: no evidence of pathogenicity. Progress in Nucleic Acid Research. New York: Academic Press.
Duesberg, P.H., 1989a. Does HIV cause AIDS? J. AIDS 2: 514–5.
Duesberg, P.H., 1989b. HIV and AIDS: correlation but not causation. Proc. Nat. Acad. Sci. USA 86: 755–62.
Duesberg, P.H., 1989c. Response to the AIDS Debate. Naturwissenchaften.
Duesberg, P.H., 1987. Retroviruses as carcinogens and pathogens: expectations and reality. Cancer Research 47: 1199–1220.
Eigen, M., 1989. The AIDS debate. Naturwissenchaften 76: 341–540.
Elangovan, B., T. Subramanian & G. Chinnadurai, 1992. Functional comparison of the basic domains of the Tat proteins of HIV types 1 and 2 in transactivation. J. Virol. 66 (4): 2031–6.
Evans, A.S., 1989a. Does HIV cause AIDS? An historical perspective. J. AIDS 2: 107–13.
Evans, A.S., 1989b. Does HIV cause AIDS? Author’s reply. J. AIDS 2: 515–7.
Fabio, R. Scorza & A. Lazzarin, 1992. HLA-associated sensitivity to HIV infection. Clin. Exp. Immunol. 87: 19–25.
Fauci, A.S., 1988. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science 239: 617–22.
Fordyce, E.J., S. Blum, A. Balanon & R.L. Stoneburner, 1991. A method for estimating HIV transmission rates among female sex partners of male intravenous drug users. Amer. J. Epid. 133: 590–8.
Gallo, R.C., S.Z. Salahuddin & M. Popovic, 1984. Frequent detection and isolation of cytopathic retroviruses (HTLV III) from patients with AIDS and at risk for AIDS. Science 224: 500–3.
Gallo, R.C., 1987. The AIDS Virus. Scientific American 39–48.
Gay, G., 1972. Epidemiologie drug trends in San Francisco. Ch 12 in Trends in Epidemiology ed Stewart, GT, Springfield, Ill: C C Thomas.
Gottlieb, M.S., 1981. Pneumocystis carinii and mucosal candidiasis in previously healthy homosexual men. New. Eng. J. Med. 305: 24.
Gunzburg, H.M., P.L. Fleming & K.D. Millar, 1988. Selected public health observations derived from the Multicenter AIDS Cohort Study. J.AIDS 1: 2–7.
Hanafusa, H., A. Pinter & M.E. Pullman (eds), 1989. Retroviruses and Disease. San Diego, CA, Academic Press.
Hawkes, S., A. Malin, T. Araru & D. Mabey, 1992. HIV infection among heterosexual travellers attending the Hospital for Tropical Diseases, London. Genito-urin. Med. 68: 309–311.
Hawkins, R.E., L.S. Hickman, S.H. Vermund & M. Carl, 1992. Association of Mycoplasma and HIV infection: detection of amplified M. fermentans DNA in blood. J. Inf. Dis. 165: 581–5.
Hilgartner, M.W., 1987. AIDS in Haemophilia. New. Eng. Med. J. 317: 1533–4.
Ho, D.D., R.J. Pomerantz & J.C. Kaplan, 1987. Pathogenesis of infection with Human Immunodeficiency Virus. New Eng. J. Med. 317: 278–285.
Innocenti, P, Ottoman & P. Morand, 1992. HIV-1 in blood monocytes: frequency of detection of proviral DNA using PCR and comparison with the total CD4 count. AIDS Res. Hum. Retro-viruses 8: 261–8.
Institute of Medicine, 1988. Confronting AIDS: Update. Washington, DC., National Academy of Science 198.
International Classification of Diseases, 10th Ed, 1992. Geneva: WHO.
Jason, J., R.C. Holman & B.L. Evatt, 1990. Relationship of partially purified concentrates to immune tests and AIDS. Am. J. Hematol. 34: 262–9.
Jin, Z., R.P. Cleveland & D.B. Kaufman, 1989. Immunodeficiency in patients with haemophilia. J. Allerg. Clin. Immunol. 83: 165–70.
Katseni, V.L., C.B. Gilroy & B.K. Ryait, 1993. Mycoplasma fermetans in individuals seropositive and seronegative for HIV-1. Lancet 341: 271–3.
Kiprov, D.D., R.D. Anderson & R Morand, 1985. Antilymphocyte antibodies and seropositivity for retroviruses in groups at high risk for AIDS. N. Eng. Med. J. 312: 1517.
Konotey-Ahulu, F.I.D., 1989. What is AIDS? Watford, UK, Tetteh-A’Domeno.
Lancet (Editorial). 1992. Risk of HIV transmission during dental treatment. 340: 1259.
Lemaitre, M., D. Guetard, Y. Henin, L. Montagnier & A. Zerial, 1990. Protective activity of tetracycline analogs against the cytopathic effect of the HIVs in CEM cells. Res. Virol. 141: 5–16.
Levy, J.A. & J. Chimabukuro, 1985. Recovery of AIDS-associated retrovirus from patients with AIDS and related conditions and healthy persons. J. Inf. Diseases 152: 734–7.
Li, P. & C.J. Burrell, 1992. Synthesis of HIV-DNA in a cell-to-cell transmission model. AIDS Res. Hum. Retroviruses 8: 253–9.
Lo, S.C., R.Y. Wang & P.B. Newton, 1989. Fatal infection of silver leaf monkey with a virus-like agent (VLA) derived from a patient with AIDS. Amer. J. Top. Med. Hyg. 40: 399–409.
Lo, S.C., 1986. Isolation and identification of a novel virus from patients with AIDS. Amer. J. Trop. Med. Hyg. 35: 675–6.
London Declaration on AIDS, 1988. The Times, London, 27 January.
Lourie, D.B., T. Hensle, & J. Rose, 1967. The major complications of heroin addiction. Arm. Int. Med. 67: 1–6.
Louwagie, F. F. McCutchan & G. Van der Groen, 1992. Genetic comparison of HIV-1 isolates from Africa, Europe and North America. AIDS Res. Hum. Retroviruses 8(8): 4167–9.
Ludlam, C.A., J. Tucker & C.M. Steel, 1985. HTLV III infection in seronegative haemophiliacs after transfusion of Factor VIII. Lancet 1: 233–6.
Ludlam, C.A., 1993. Personal communication.
Ma, P. & D. Armstrong (eds), 1989. AIDS and infections of homosexual men. 2nd Ed. Boston Butterworths.
Makris, M., F.E. Preston & D.R. Triger, 1990. CMV infection and progress towards AIDS in haemophiliacs with HIV infection. Lancet 1: 117–9.
Mann, J.M., (WHO), 1989. AIDS: a worldwide pandemic. Current Topics on AIDS 2: 1–10.
Marcus, R., 1988. CDC Needle Stick Surveillance of health care workers exposed to blood from patients infected with HIV. New Eng. Med. J. 319: 1118–32.
Marmor, M., A.E. Friedman-Kien & L. Laubenstein, 1982. Risk factors for Kaposi’s sarcoma in homosexual men. Lancet 1: 1083.
Mavligit, G.M., Talpag & F.T. Hsia, 1984. Chronic immunological stimulation by sperm alloantigens. J. Amer. Med. Assoc. 251: 237–41.
McClure, M.O. & T.F. Schultz, 1989. Origins of HIV. Brit. Med. J. 289: 1267–8.
McClure, M.O. & A.G. Dalgleish, 1992. Human immunodeficiency virus and the immunology of infection. Baillere’s Clin. Obst. Gynaecol. 6: 1–12.
McDonough, R.J., J.J. Madden & A. Falek, 1980. Alterations in T and null lymphocyte frequency in the peripheral blood of hu man opiate addicts. J. Immunol. 125: 2539.
Medical Research Council, The Edinburgh Haemophiliac Cohort, 1990. Project Report: MRC, London (Update).
Meyer, K.B. & S.G. Panker, 1987. Screening for HIV:L can we afford the false-positive rate? New Eng. J. Med. 317: 238–41.
Midthum, K., G. Garrison & M.L. Clements, 1990. Frequency of indeterminate Western Blot tests in healthy adults at low risk for HIV infection. J. Inf. Dis. 162: 1379–82.
Mirvish, S.S. & H.W. Haverkos, 1987. Butyl nitrate in the induction of Kaposi’s sarcoma in AIDS. New Eng. J. Med. 317: 1103.
Montagnier, L., 12th March, 1994. Quoted by the Times, London.
Morb. Mort. Wkly. Reports. 1981; 30,250,305,409; and 1982; 31, 37, 507; and Special Report on Surveillance to 1989. Center for Disease Control, Atlanta, Ga.
Mortimer, P.P., 1991. The fallibility of HIV western blot. Lancet 37: 286–7.
Moss, A.R., D. Osmond & P. Bacchetti, 1987. Risk factors for AIDS and seropositivity in homosexual men. Amer. J. Epid. 125: 1035–47.
Moss, A.R., 1987. AIDS and intravenous drug use: the real heterosexual epidemic. Brit. Med. J. 249: 389–90.
New York City, Dept. of Health. 1982–92. AIDS Surveillance Updates.
Newell, G.R., P.W. Mansell & M.R. Spitz, 1985. Volatile nitrites: use and adverse effects in relation to the current epidemic of AIDS. Amer. J. Med. 78: 811–6.
Ozturk, G.E., P.F. Koller & C.R. Horsburgh, 1987. The significance of antilymphocyte antibodies in patients with AIDS and their sexual partners. J. Clin. Immunol. 7: 130–133.
Pagano, M., V. DeGruttola, S. MaWhinney & X.M. Tu, 1991. The HIV Epidemic in New York City; Projecting AIDS Incidence and Prevalence. Report prepared under contract with New York City.
Papadopulos-Eleopulos, E. & V.F. Turner, 1993. Is the Western Blot proof of HIV infection? Biotechnol. 11: 696–707.
Pfutzner, A., U. Dietrich & U. Von Eichel, 1992. HIV-I and HIV-2 infections in Bombay, India: evidence for spread of HIV-2 and presence of a divergent HIV-1 sub-type. J. AIDS 5 (10): 972–7.
Pruzanski, W., H. Jacobs & L.P. Laing, 1983. Lymphocytotoxic antibodies against peripheral blood B- and T-lymphocytes in homosexuals with AIDS and ARC. AIDS Res. 1: 211–220.
Public Health Laboratory Service, 1993. Comm. Dis. Rep. 3 (4): 22nd January.
Public Health Laboratory Service and the Communicable Diseases (Scotland) Unit. 1982–92. AIDS/HIV Quarterly Surveillance Tables.
Quarantino, S., G. Munson & R.E. Knyba, 1991. Human CD4–CD8alpha-beta+T-cells express a functional T-cell receptor and can be activated by superantigens. J. Immunol. 147: 3319–3323.
Quinn, C., R. Piot & J.B. MacCormick, 1987. Serological and immunological studies in patients with AIDS in North America and Africa. JAMA 257: 2617–21.
Ragni, M.V., L.A. Kingsley & P. Nimorwicz, 1989. HIV heterosexual transmission in haemophilia couples. J. Acq. Immune Defic. Syndrome 2: 557–63.
Ragni, M.V., A. Winkelstein & L.A. Kingsley, 1987. 1986 update of HIV seroprevalence, seroconversion and AIDS incidence and immunological correlates of HIV infection in patients with haemophilia. Blood 70: 786–90.
Revision of the CDC surveillance case definition for AIDS, 1987. Morb. Mort. Wkly. Reports 36: supp 3–5. Center for Disease Control, Atlanta, Ga.
Root-Bernstein, R.S., 1992. Multiple antigen-mediated autoimmunity (MAMA) in AIDS: a possible model for post-infectious autoimmune complications. Res. Immunol. 141: 321–339.
Root-Bernstein, R., 1993. Rethinking AIDS. New York: Macmillan.
Root-Bernstein, R.S. & S.H. Hobbs, 1991. Homologies between Mycoplasma adhesion peptide, CD4 and CLASS II MHC proteins. Res. Immunol. 142: 519–523.
Rubin, H., 1988. Etiology of AIDS. Science 240: 1389.
Sato, P.A., J.A. Chin & J.M. Mann (WHO), 1989. Review of AIDS and HIV infection: global epidemiology and statistics. AIDS 3 (supp) S: 301–7.
Schoental, R, 1988. AIDS and neoplasias associated with AIDS. Inter. J. Env. Studies 31: 269–78.
Seale, J., 1988. Origin of the AIDS viruses, HIV-1 and HIV-2: fact or fiction? Discussion paper. J. Roy. Soc. Med. 81: 537–9.
Seale, J.R., 1987. Pathogenesis and transmission of AIDS. Veterinary Record 120: 454–9.
Selwyn, P.A., 1989. Issues and the clinical management of IVDU with HIV infection. AIDS 3: suppl 1; 201–8.
Seremetis, S., L.M. Aledort & H. Sacks, 1990. Differential effects of CD4 counts of high or intermediate purity Factor VIII concentrates in HIV+ haemophiliacs. Blood 76: 48a and Coagulation Abstracts III 1455.
Serwadda, D., N.K. Sewankambo & J.W. Carswell, 1985. Slim Disease: a new disease in Uganda and its association with HTLV III in fection. Lancet 11: 850–2.
Sheppard, H.W. & H. Ascher, 1992. The relationship between AIDS and immunologic tolerance. J. AIDS 5: 143–7.
Sheppard, H.W. & M.S. Ascher, 1990. AIDS and programmed cell death. Immunol. Today 12: 423.
Shilts, R., 1987. And the Bank Played On. New York: Penguin Press. Shioda, T. & J.A. Levy, 1992. Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell line and macrophage tropism of HIV-1. Proc. Nat. Acad. Sci. USA 89: 9434–8.
Sonnabend, J., 1989. Facts and speculation about the cause of AIDS. AIDS Forum 2: 3–12.
Spencer, L.T., M.T. Ogino, W.M. Danker & S.A. Spector, 1994. Clinical significance of HIV type 1 phenotypes in infected children. J. Inf. Dis. 169: 491–5.
Sprent, J., E.K. Gao & S.R. Webb, 1990. T-cell reactivity to MHC molecules: tolerance v. intolerance. Science 248: 1357–63.
Steel, C.M., D. Beatson & R.J.G. Cuthbert, 1988. HLA haplotype Al B8 DR3 as a risk factor for HIV-related disease. Lancet 1: 1185–8.
Stewart, G.T., 1992–3. Epidemiology and Transmission of AIDS. Soc. Pub. Hlth., Official Handbook 19–24, London: Meadow-bank Pub.
Stewart, G.T., 1991. AIDS in the UK. Estimates of differences by risk group denominators. AIDS News Supplement, Comm. Dis. Scotland Weekly Report 24: 1–3.
Stewart, G.T., 1993. AIDS predictions in the UK. Lancet 342: 437.
Stewart, G.T., 1990. AIDS. Differences within the UK. AIDS News Supplement, Comm. Dis. Scotland Weekly Report 33: 1–3.
Stewart, G.T., 1992. Changing case-definition for AIDS. Lancet 340: 1414.
Stewart, G.T. 1993. Errors in predictions of the incidence and distribution of AIDS. Lancet 342: 437.
Stewart, G.T., 1990. The Times, London 24 January.
Stewart, G.T., 1989. Uncertainties about AIDS and HIV. Lancet 336: 1325.
Stoneburner, R.L., M.A. Chiasson, LB. Weisfuse & P.A. Thomas 1990. Editorial Review. The epidemic of AIDS and HIV-1 infection among heterosexuals in New York City. AIDS 4: 99–106.
Stricker, R.B., T.M. McHugh & T.J. Moody, 1987. Prevalence of an AIDS-related autoantibody against CD4+ T cells in humans and monkeys. Blood 70: 127.
Tsoulkas, C., F. Gervais, J. Shuster & P Gold, 1984. Association of HTLV III antibodies and cellular immune status of haemophiliacs. New Eng. J. Med. 311: 1514–5.
US Centers for Disease Control, 1993. Revised Classification System for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morb Mortal Wkly Rep 1992 41: 1–19; with Addendum to the Proposed Expansion of the AIDS Surveillance Case Definition. Oct 22, 1992: Atlanta, Ga.
US Dept of Health and Human Services: HIV/AIDS Surveillance, 1982–1992. Centers for Disease Control, Atlanta, Ga.
Vandenbroncke, J.P. & V.P.A.M. Pardoel, 1989. Autopsy of epidemiological methods: the case of Poppers in the early epidemiology of AIDS. Amer. J. Epid. 129: 455–7.
Vartamian, J-P., A. Meyerhans & H.M. Wain-Hobson, 1992. High-resolution structure of an HIV-1 quasi-species: identification of novel coding sequences. AIDS 6: 1095–8.
von Boehmer, H. & P. Kisielow, 1990. Self non-self discrimination by T-cells. Science 248: 1369–73.
Wain-Hobson, S., 1989. HIV genome variability in vivo. AIDS 3: supp 1; 13–9.
Wallace, R., 1991. Travelling waves of HIV infection on a low-dimensional socio-geographic network. Soc. Sci. Med. 32: 847–52.
Ward, J.W., T.J. Bush & H.A. Perkins, 1989. The natural history of transfusion-associated infection with HIV. New Engl. J. Med. 321: 947
Webster, A., C.A. Lee & D.G. Cook, 1989. CMV infection and progress towards AIDS in haemophiliacs with HIV infection. Lancet 2: 63–65.
Weiss, R.A. & H.W. Jaffe, 1990. Duesberg, HIV and AIDS. Nature 345: 654–70.
Winkelstein, W.W., J.A. Wiley & S. Padian, 1988. The San Francisco mens’ study: continued decline in HIV seroconversion rates among homosexual-bisexual men. Amer. J. Pub. Hlth. 78: 14724.
Witkin, S.S. & J. Sonnabend, 1983. Immune response to spermatozoa in homosexual men. Fertil. Sterlisation 39: 337–42.
World Health Organisation, 1948–92. Weekly epidemiological reports.
Zacharchuck, C.M., M. Mercep & P.K. Chakraborti, 1990. Programmed T-lymphocyte death. J. Immunol. 145: 4037–4045.
Zwart, G., J.J. de Jong & T. Wolfs, 1990. Predominance of HIV serotype distinct from LAV 1/HTLV III. Lancet 1: 474.
Author information
Authors and Affiliations
Editor information
Rights and permissions
Copyright information
© 1996 Kluwer Academic Publishers
About this chapter
Cite this chapter
Stewart, G.T. (1996). The epidemiology and transmission of AIDS: a hypothesis linking behavioural and biological determinants to time, person and place. In: Duesberg, P.H. (eds) AIDS: Virus- or Drug Induced?. Contemporary Issues in Genetics and Evolution, vol 5. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-1651-7_14
Download citation
DOI: https://doi.org/10.1007/978-94-009-1651-7_14
Publisher Name: Springer, Dordrecht
Print ISBN: 978-0-7923-3961-8
Online ISBN: 978-94-009-1651-7
eBook Packages: Springer Book Archive